|
|
||||||||
Sign In to gain access to subscriptions and/or personal tools. |
|||||||||
DRUG METABOLISM |
From Drug Metabolism and Toxicology, Division of Pharmaceutical Sciences, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan (Dr Nakajima, Ms Itoh, Ms Yamanaka, Ms Fukami, Dr Yokoi); Department of Legal Medicine, Dokkyo University School of Medicine, Mibu, Tochigi, Japan (Dr Tokudome); and Department of Biochemistry, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan (Dr Y Yamamoto, Dr H Yamamoto).
The inhibitory effects of isoflavones (daidzein, genistein, and glycitein) on human cytochrome P450 (CYP) 2A6 activities were investigated. Daidzein, genistein, and glycitein uncompetitively inhibited nicotine C-oxidation catalyzed by recombinant CYP2A6 expressed in baculovirus-infected insect cells with Ki values of 1.3 ± 0.3 µM, 0.7 ± 0.2 µM, and 5.2 ± 0.8 µM, respectively, but not coumarin 7-hydroxylation. Effects of the intake of soy isoflavones on in vivo nicotine metabolism were investigated with 7 healthy Japanese homozygotes of CYP2A6*1. The cotinine/nicotine ratio of the plasma concentrations 2 hours after chewing 1 piece of nicotine gum under the basal condition (after abstaining from soy foods for 1 week) was 8.8 ± 2.6 (4.4-11.4). The ratio was significantly (P< .05) reduced to 6.7 ± 1.6 (4.0-8.2) after consumption of a soy isoflavone supplement (60 mg of total isoflavones/d) for 5 days. The authors found that isoflavone contained in soy products significantly decreased nicotine metabolism.
Key Words: Cytochrome P450 CYP2A6 isoflavones coumarin nicotine metabolism
Address for reprints: Miki Nakajima, PhD, Drug Metabolism and Toxicology, Division of Pharmaceutical Sciences, Graduate School of Medical Science, Kanazawa University, Kakuma-machi, Kanazawa 920-1192, Japan; e-mail: nmiki{at}kenroku.kanazawa-u.ac.jp.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
E. Higashi, M. Nakajima, M. Katoh, S. Tokudome, and T. Yokoi Inhibitory Effects of Neurotransmitters and Steroids on Human CYP2A6 Drug Metab. Dispos., April 1, 2007; 35(4): 508 - 514. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |